Treatment of severe acute graft-versus-host disease refractory to multiple lines of therapy: Real-world data from 317 adults treated with the multiple-donor bone marrow-derived mesenchymal stromal cell preparation tomostrocel

M Verbeek, H Bonig, F Ayuk, G Bug, M D'Aveni-Piney, D Heidenreich, P Herhaus, U Holtick, I Kos, W Krüger, MT Lupo-Stanghellini, T Mika, C Neuerburg, E Osswald, V Panagiota, C Reicherts, C Schmid, M Srour, F Stölzel, M Tribanek, F Wortmann, G Wulf, A Zens, R Zeiser

Open source

DOI: 10.1016/j.jtct.2026.09.021
Published: 2026-09
Container: Transplantation and Cellular Therapy
Publisher: Elsevier BV
Open access: unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

supportingDOI registered: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
supportingDOI resolves: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
supportingMetadata completeness: All 6 scored descriptive metadata groups are present. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1016/j.jtct.2026.09.021,
  title = {Treatment of severe acute graft-versus-host disease refractory to multiple lines of therapy: Real-world data from 317 adults treated with the multiple-donor bone marrow-derived mesenchymal stromal cell preparation tomostrocel},
  author = {M Verbeek and H Bonig and F Ayuk and G Bug and M D'Aveni-Piney and D Heidenreich and P Herhaus and U Holtick and I Kos and W Krüger and MT Lupo-Stanghellini and T Mika and C Neuerburg and E Osswald and V Panagiota and C Reicherts and C Schmid and M Srour and F Stölzel and M Tribanek and F Wortmann and G Wulf and A Zens and R Zeiser},
  year = {2026},
  journal = {Transplantation and Cellular Therapy},
  doi = {10.1016/j.jtct.2026.09.021},
  url = {https://doi.org/10.1016/j.jtct.2026.09.021}
}

RIS

TY  - JOUR
TI  - Treatment of severe acute graft-versus-host disease refractory to multiple lines of therapy: Real-world data from 317 adults treated with the multiple-donor bone marrow-derived mesenchymal stromal cell preparation tomostrocel
AU  - M Verbeek
AU  - H Bonig
AU  - F Ayuk
AU  - G Bug
AU  - M D'Aveni-Piney
AU  - D Heidenreich
AU  - P Herhaus
AU  - U Holtick
AU  - I Kos
AU  - W Krüger
AU  - MT Lupo-Stanghellini
AU  - T Mika
AU  - C Neuerburg
AU  - E Osswald
AU  - V Panagiota
AU  - C Reicherts
AU  - C Schmid
AU  - M Srour
AU  - F Stölzel
AU  - M Tribanek
AU  - F Wortmann
AU  - G Wulf
AU  - A Zens
AU  - R Zeiser
PY  - 2026
JO  - Transplantation and Cellular Therapy
DO  - 10.1016/j.jtct.2026.09.021
UR  - https://doi.org/10.1016/j.jtct.2026.09.021
ER  -

APA

Verbeek, M., Bonig, H., Ayuk, F., Bug, G., D'Aveni-Piney, M., Heidenreich, D., Herhaus, P., Holtick, U., Kos, I., Krüger, W., Lupo-Stanghellini, M., Mika, T., Neuerburg, C., Osswald, E., Panagiota, V., Reicherts, C., Schmid, C., Srour, M., Stölzel, F., Tribanek, M., Wortmann, F., Wulf, G., Zens, A., & Zeiser, R. (2026). Treatment of severe acute graft-versus-host disease refractory to multiple lines of therapy: Real-world data from 317 adults treated with the multiple-donor bone marrow-derived mesenchymal stromal cell preparation tomostrocel. Transplantation and Cellular Therapy. https://doi.org/10.1016/j.jtct.2026.09.021

Source records

crossref · retrieved 2026-09-25T09:09:40.182Z